U.S., June 12 -- ClinicalTrials.gov registry received information related to the study (NCT07016412) titled 'A Phase IIb Ensifentrine-glycopyrrolate Fixed-dose Combination Dose Ranging Study in Subjects With COPD' on June 03.
Brief Summary: This study will assess the safety and efficacy of fixed dose combinations of ensifentrine with two different glycopyrrolate dose levels compared to placebo and to the individual components of the fixed dose combinations, each administered twice a day via standard jet nebulizer, in adult subjects with chronic obstructive pulmonary disease (COPD).
Study Start Date: July 31
Study Type: INTERVENTIONAL
Condition:
Chronic Obstructive Pulmonary Disease
Intervention:
DRUG: Ensifentrine 3 mg
Administered ...